The possibilities of molecular-genetic research methods are actively used in the diagnosis of various diseases: for example, mutations in the BRCA 1 and BRCA 2 genes in the diagnosis of breast and ovarian cancers [39,40] and the analysis of the FMR1 gene in the prognosis of primary ovarian insufficiency risks [41]. The gene discussed is FMR1; the disease is ovarian carcinoma.